EGFR somatic variants
About
Gene context: EGFR
Biomarker Type: Somatic Variant
Present: True
Chromosome: 7
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | EGFR somatic variants | Non-Small Cell Lung Cancer | Afatinib | |
| EMA (1) FDA (1) | EGFR somatic variants | Non-Small Cell Lung Cancer | Atezolizumab | |
| EMA (1) | EGFR somatic variants | Non-Small Cell Lung Cancer | Atezolizumab, Bevacizumab, Carboplatin, Paclitaxel | |
| FDA (1) | EGFR somatic variants | Non-Small Cell Lung Cancer | Datopotamab deruxtecan |